AzTrials
AzTrials

E-cigarette UseNCT05949034

Effects of E-Cigarettes in Menthol Smokers

A study testing JUUL E-Cigarette Device in people with E-cigarette Use and Smoking Behaviors, run by University of Southern California at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current laboratory study examines e-cigarette preferences and smoking behaviors in menthol cigarette smokers. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
E-cigarette Use, Smoking Behaviors
What is being tested?
JUUL E-Cigarette Device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteUnited States
Study dates
1 Jul 2019to 14 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Daily cigarette smoking for at least the past 2 years
  • Interest in trying e-cigarettes
  • Report smoking mentholated cigarettes

Who cannot join

  • -- Pregnancy and/or breastfeeding

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Southern California

    Los Angeles, California, 90033

Other trials in United States

About this study

The current laboratory study examines e-cigarette preferences and smoking behaviors in menthol cigarette smokers.

Being tested
JUUL E-Cigarette Device
Keywords
menthol, cigarette, smoking
Medical subject headings
Vaping, Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • JUUL E-Cigarette DeviceDevice

    We will use the commercially available and popular JUUL e-cigarette device and e-cigarette solutions.

Study groups in NCT05949034
Study groupRoleWhat they receive
E-Cigarette Flavor 1 ConditionExperimentalParticipants will self-administer a flavored e-cigarette.
Receives: Device: JUUL E-Cigarette Device
E-Cigarette Flavor 2 ConditionExperimentalParticipants will self-administer a flavored e-cigarette.
Receives: Device: JUUL E-Cigarette Device
E-Cigarette Flavor 3 ConditionExperimentalParticipants will self-administer a flavored e-cigarette.
Receives: Device: JUUL E-Cigarette Device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preference Ratings

    Self-report measures of product preference will be completed following the e-cigarette self-administration. Scores can range from 0 to 100 for the preference rating, with lower scores representing less preference and higher scores representing higher preference.

    Measured: 1 hour

  2. Mood - Positive Affect Negative Affect Schedule

    This measure is obtained through the completion of the Positive Affect Negative Affect Schedule. A total score will be calculated for both Positive and Negative Affect. Scores can range from 10 to 50 for both the Positive and Negative Affect, with the lower scores representing lower levels of Positive/Negative Affect and higher scores representing higher levels of Positive/Negative Affect.

    Measured: 4 hours

  3. Mood - Profile of Mood States

    This measure is obtained through the completion of the Profile of Mood States. A total score will be calculated. Scores can range from 10 to 260, with the lower scores representing lower levels of mood disturbance and higher scores representing higher levels of mood disturbance.

    Measured: 4 hours

  4. Cigarette Craving

    This measure is obtained through the completion of the Brief Questionnaire of Smoking Urges. A total score will be calculated. Scores can range from 10 to 70, with the lower scores representing a lower level of cigarette craving and higher scores representing greater levels of cigarette craving.

    Measured: 4 hours

  5. Nicotine Withdrawal - Minnesota Nicotine Withdrawal Scale

    This measure is obtained through the completion of the Minnesota Nicotine Withdrawal Scale. A total score will be calculated. Scores can range from 0 to 32, with the lower scores representing a lower level of nicotine withdrawal and higher scores representing greater levels of nicotine withdrawal.

    Measured: 4 hours

  6. Nicotine Withdrawal - Wisconsin Smoking Withdrawal Scale

    This measure is obtained through the completion of the Wisconsin Smoking Withdrawal Scale. A total score will be calculated. Scores can range from 0 to 112, with the lower scores representing a lower level of nicotine withdrawal and higher scores representing greater levels of nicotine withdrawal.

    Measured: 4 hours

  7. Smoking Motivation

    This measure is obtained through the completion of a computerized behavioral task.

    Measured: 2 hours after experimental session outset

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2023
  2. Study start1 Jul 2019
  3. Primary completion14 Nov 2020
  4. Study completion14 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05949034
Sponsor's protocol ID
HS-19-00325
Status last verified
Jul 2023
First submitted
29 May 2019
Last updated
20 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing JUUL E-Cigarette Device in people with E-cigarette Use and Smoking Behaviors, run by University of Southern California at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preference Ratings (time frame: 1 hour). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in